Patients with obstructive sleep apnea syndrome (OSAS) may be exquisitely sensitive to central nervous system depressant drugs showing potential for upper airway obstruction or apnea with even minimal doses of these drugs [1, 2] . The anesthetic complications in OSAS patients may be due to multiple factors including collapse of the upper airway, type of surgery and anesthesia, and other associated conditions such as obesity. Since gastrointestinal endoscopy is a medical procedure requiring an anesthetic or analgesic, complications may be expected to occur more frequently in patients with OSAS.
For years, surgical risks for OSAS patients have been underestimated [3] . More recently, specific recommendations for the surgical care of patients with OSAS have been introduced in the guidelines of different anesthetic societies [4] , in specific statements of management of patients with OSAS [5, 6] , and more recently in the standards of sedation of patients who undergo gastrointestinal endoscopy [7] . In this regard, the Clinical Practice Review Committee of the American Academy of Sleep Medicine [8] has recommended that patients with a high index of suspicion for OSAS who are undergoing surgical procedures have (1) airway monitoring throughout the surgical period, (2) judicious use of appropriate anesthetic medication, and (3) monitoring throughout the process, especially during the postoperative period. Subsequently, the American Society of Anesthesiology [4] published a practical guide to the anesthetic care of OSAS patients. The guide was a consensus document based on existing literature and expert opinion, but as with other guides, implementation in clinical practice has been slow.
Gastrointestinal endoscopy is a safe procedure with a low event rate of serious cardiopulmonary complications. To make gastrointestinal endoscopic procedures better tolerated by the patient, utilization of light-to-moderate sedation is considered standard, and its use is routine. Most sedating medications used in anesthesia reduce the activity of airway muscles, favoring airway collapse. In OSAS patients, this phenomenon is aggravated by decreased ventilatory responses to hypoxia and hypercapnia and inhibited arousal responses to protect against apnea. Furthermore, obesity must be taken into account, in that obesity itself increases operative risk and is highly associated with OSAS. Furthermore, some of the drugs used in sedation must be adjusted to ideal weight.
Although the problem frequently arises in clinical practice, only a few studies, mainly retrospective, have evaluated the cardiovascular complications in patients with OSAS who were subjected to a digestive endoscopic procedure under light-to-moderate sedation [9] [10] [11] [12] [13] [14] . In some studies, a clinical questionnaire was used before endoscopy to stratify patients into categories of high or low probability for OSAS. The Berlin questionnaire [15] was used by Khiani [9] and Mador [12] . Assessing the incidence of desaturations (<92%) during endoscopy, Khiani found no differences between groups at low and high risk for OSAS. The Mador study [12] , published in this issue of Sleep and Breathing, showed that patients with high probability of OSAS who are subjected to gastrointestinal endoscopic procedures have no greater number of complications, both major and minor compared to patients with low probability of OSAS. These findings do not support the research by Cote [13] that demonstrated more oxygen desaturations and ventilatory problems in patients with suspected OSAS using a clinical questionnaire (STOP-BANG), but in this study, the patients had advanced endoscopic procedures.
With respect to studies involving a polysomnographic diagnosis, Mador [10] did not find a higher number of complications in patients with OSAS, regardless of the cutoff for diagnosis of OSAS or its severity. However, polysomnography was performed before endoscopy in only 63.5% of cases and preceded the procedure by a median of 1.84 years. In a retrospective study, Adler [11] claimed the safe use of propofol in endoscopic procedures finding no significant differences in the number of complications in patients with OSAS and patients without OSAS. However, a limitation of this study was that it did not account for patients treated with CPAP. Gill [14] , using a case-control design in a veteran population, did not find differences in the number of complications from endoscopic procedures.
Another aspect that should be considered is the administration of oxygen therapy in routine endoscopy. One of the most frequent cardiorespiratory complications in patients who undergo endoscopy with or without sedation is transient hypoxemia which can range in frequency between 10% and 70%, depending on the definition of hypoxemia, the underlying disease, previous baseline saturation, type of endoscopy and sedation used. The mechanisms of hypoxemia in this situation are multifactorial, but hypoventilation plays a key role. The use of oxygen is common in most endoscopy units. Its use can prevent the occurrence of hypoxemia, although its routine use is controversial especially in patients with COPD. Furthermore, it is not clearly established what constitutes an adequate oxygen flow and how protocols for the administration of oxygen should change in the presence of comorbidities such as obesity. Mador and colleagues [10] add to our understanding with their study demonstrating that the increased oxygen flow of 4 L/min in obese patients reduces the number of desaturations.
In conclusion, evidence to date suggests that the presence of OSAS is not a contraindication for the use of sedation in gastrointestinal endoscopic procedures when properly monitored, regardless of the type of sedation and particular endoscopic procedure performed.
